Inactive Instrument

Press Releases ESSA Pharma Inc. Toronto S.E.

Equities

EPI

CA29668H7085

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

ESSA Pharma: Fiscal Q2 Earnings Snapshot	14/05	AQ
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024	14/05	PR
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	09/04	PR
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	08/03	PR
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	08/03	AQ
ESSA Pharma : Passive Foreign Investment Company Statement	28/02	PU
ESSA Pharma: Fiscal Q1 Earnings Snapshot	13/02	AQ
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023	13/02	AQ
ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02	PR
ESSA Pharma Presents Updated Phase 1 Masofaniten Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	26/01	AQ
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	25/01	PR
ESSA Pharma: Fiscal Q4 Earnings Snapshot	12/12	AQ
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023	12/12	AQ
ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference	21/11	PR
ESSA Pharma to Present at the Jefferies London Healthcare Conference	08/11	PR
ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement	07/11	PR
ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement	07/11	AQ
ESSA Pharma : Enters into At-The-Market Equity Offering Sales Agreement - Form 8-K	07/11	PU
ESSA Pharma Presents Updated Phase 1 Masofaniten Clinical Data at the 30th Annual Prostate Cancer Foundation Scientific Retreat	27/23/27	AQ
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 30th Annual Prostate Cancer Foundation Scientific Retreat	27/23/27	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ESSA Pharma Inc. Toronto S.E.

Equities

EPI

CA29668H7085

Press Releases

Filters